Epichlorohydrin (1-chloro-2,3-epoxypropane, CAS 106-89-8, EC 203-439-8) is listed on Annex XIV of Regulation (EC) No 1907/2006 as a substance of very high concern identified under Article 57(a) for its harmonised classification as carcinogen category 1B under Regulation (EC) No 1272/2008. Annex XIV listing triggers the authorisation obligation in Article 56(1), but that obligation is not absolute. Article 56(5) excludes uses as on-site isolated intermediates and transported isolated intermediates from the authorisation requirement, provided the strictly controlled conditions set out in Article 17(3) or Article 18(4) are maintained. Because the largest tonnage of ECH consumed in the EU is used as a chemical intermediate in closed conversion to bisphenol A diglycidyl ether, synthetic glycerol, and glycidyl derivatives, the intermediate exemption determines whether a given ECH stream remains lawful without an authorisation.

The classification of ECH as carcinogenic under CLP does not remove the substance from all industrial use. REACH authorisation operates on a use-specific basis. A substance included in Annex XIV may still be consumed as an intermediate without an application to the European Chemicals Agency, whereas the same substance placed on the market for formulation into an adhesive, coating, or laboratory reagent requires an authorisation after the Annex XIV sunset date. This creates distinct compliance checkpoints at reactor level, storage level, and contract level.

Which Operational Configurations Satisfy the Isolated Intermediate Exemption for Epichlorohydrin?

Article 3(15) defines an intermediate as a substance manufactured for and consumed in or used for chemical processing to be transformed into another substance. An isolated intermediate is one that has been removed from the production vessel and stored or transferred before further reaction. ECH is normally isolated by distillation from the crude chlorohydrin or glycerol hydrochlorination reaction mixture before conversion to downstream derivatives, so it falls under the isolated rather than the non-isolated subcategory.

For on-site isolated intermediates, REACH requires that manufacture and transformation occur on the same site, which may be operated by one or more legal entities, and that the site operator maintains strictly controlled conditions in accordance with Article 17(3). In an integrated ECH-to-epoxy-resin plant, this is met when distilled ECH is held in nitrogen-blanketed storage, transferred through closed lines to the epoxidation reactors, and consumed in a closed reactor train. The exemption is lost if ECH is sold from that same site for a formulated end-use without transformation.

In a standard liquid epoxy resin operation, bisphenol A and a stoichiometric excess of ECH are reacted in a two-phase alkaline system. The resulting bisphenol A diglycidyl ether is washed, dehydrated, and distilled to produce a resin with an epoxide equivalent weight in the range 182–192 g/eq and a dynamic viscosity of 11–14 Pa·s at 25 °C when tested according to ASTM D1652. In this configuration ECH is consumed in the epoxidation reactor and is not a deliberate component of the final resin. The on-site isolated intermediate exemption applies to the ECH that is converted in the same site operation; the resulting liquid epoxy resin is a separate substance for REACH purposes.

Two commercial ECH production routes exist: the conventional propylene-based chlorohydrin process and the glycerol-to-ECH process. The glycerol route uses crude glycerol from biodiesel production, hydrochloric acid, and a catalyst such as acetic acid. The reaction sequence generates 1,3-dichloropropan-2-ol, which is dehydrochlorinated with sodium hydroxide to ECH. The distillation step separates ECH from water and dichloropropanol. In both routes, the ECH product is isolated before derivative manufacture, so the isolated intermediate provisions are relevant.

A recurrent compliance question is whether ECH used in epoxy resin synthesis is an intermediate or a monomer. Under REACH, monomer status affects polymer registration, but the authorisation exemption depends on the intermediate definition in Article 3(15). When ECH is consumed in a chemical reaction to produce a different substance, such as bisphenol A diglycidyl ether, and the process is closed, the use may qualify as an intermediate use. However, the qualification is fact-specific: if ECH is placed on the market as a component of a mixture that will react only later in a customer’s formulation, the substance has been placed on the market for a non-intermediate use, regardless of any later reaction.

Registration and authorisation are separate REACH obligations. Exemption from authorisation under Article 56(5) does not remove the requirement to register ECH as an intermediate when the quantity reaches 1 t/y per legal entity. On-site isolated intermediates are registered under Article 17 with available information and without a chemical safety report. Transported isolated intermediates are registered under Article 18 with a reduced information package compared with full registration. The reduced data package is acceptable only when the strictly controlled conditions are maintained.

Transported Isolated Intermediate Controls for Purchased Epichlorohydrin

When ECH is shipped to an epoxy resin or glycerol producer at a different site, the transported isolated intermediate exemption in Article 56(5) applies only if the receiving site handles the substance under strictly controlled conditions as defined in Article 18(4). The written contract between the supplier and the downstream user should designate the substance as a transported isolated intermediate, specify the controlled use, and impose obligations for closed transfer, restricted access, trained personnel, and waste treatment. A distributor arrangement without a direct strictly controlled conditions contract can break the exemption chain, because the substance is then placed on the market for a use rather than supplied as an intermediate.

At the receiving site, the ECH storage system is typically a pressure-rated or nitrogen-blanketed tank connected to the reactor by hard-piped stainless steel lines. Transfer pumps are equipped with dual mechanical seals and leak detection. Vapour returns are routed to a scrubber or thermal oxidiser. Worker exposure may be monitored by photoionisation detection at flange pairs and pump glands. These measures are the operational evidence that the receiving process falls within Article 18(4) strictly controlled conditions.

For ECH imported into the EU as a transported isolated intermediate, the importer must ensure that the non-EU supplier provides the necessary information for registration and that the receiving site’s strictly controlled conditions are documented before first shipment. ECHA’s Guidance on intermediates states that the exemption cannot be claimed retrospectively; the operator must have the strictly controlled conditions system in place at the time the substance is received.

When ECH Is Placed on the Market for Formulation Rather Than Transformation

If ECH is supplied to a formulator for conversion into a product without strictly controlled conditions, or sold through a distributor with no directly enforceable strictly controlled conditions contract, the isolated intermediate exemption does not apply. The supply is then a placement on the market for a use that is subject to Article 56(1). After the Annex XIV sunset date, such uses require an authorisation granted by the European Commission, and the formulator must ensure that its use is covered by the supplier’s authorisation or by its own downstream user notification under Article 66(1).

Article 56(5) contains additional use-specific exemptions for plant protection products, biocidal products, motor fuels, medicinal products, food or feedingstuffs, and cosmetic products. These are not relevant to industrial ECH consumption. There is no general exemption for small-tonnage use or for closed-loop use unless the isolated intermediate conditions are met.

For non-exempt ECH uses, an application for authorisation must be submitted under Article 62 and must include a chemical safety report, an analysis of alternatives, and a socio-economic analysis. The European Chemicals Agency’s Risk Assessment Committee and Socio-economic Analysis Committee deliver opinions under Article 64. The European Commission may grant a time-limited authorisation with review periods, and downstream users relying on that authorisation must notify ECHA under Article 66(1). Authorisation is use-specific and supplier-specific; a downstream user cannot assume that an authorisation held by one supplier covers ECH purchased from another supplier.

The Annex XIV authorisation obligation has no lower tonnage threshold. A non-exempt ECH use at 0.1 t/y requires the same authorisation validity as a 1000 t/y use. The intermediate exemption, by contrast, applies irrespective of tonnage as long as the operational conditions are met.

Documented Strictly Controlled Conditions Are the Operative Boundary of the Exemption

The intermediate exemption is not self-executing. The operator must be able to demonstrate through written procedures, maintenance records, and training logs that the ECH stream is handled in closed systems, that access is restricted to trained personnel, and that releases are controlled. If an inspection finds open venting or unqualified personnel, the exemption is unavailable and the use can be considered unlawful after the Annex XIV sunset date. Documentation should align with the ECHA Guidance on intermediates and should specify the reactor system, storage vessel, transfer line, and waste treatment unit associated with the ECH stream.

A critical operational boundary is the transition between intermediate use and placement on the market. If a transported isolated intermediate is offloaded into a tank that also serves a formulated product line, the commingling can defeat the exemption. Similarly, if ECH is repackaged into drums for distribution to multiple small consumers, the original isolated intermediate status is not preserved unless each receiving site operates under a strictly controlled conditions contract. In such cases, the REACH obligation reverts to Article 56(1), and the supplier must hold a valid authorisation before placing the substance on the market for that use.